
Amdocs is a software-infrastructure business based in the US. Amdocs stocks (DOX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $77.11 – an increase of 6.92% over the previous week. Amdocs employs 29,000 staff and has a trailing 12-month revenue of around $4.3 billion.
How to buy stocks in Amdocs
- Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – DOX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Finder's Pick for
Beginners

Finder's Pick for
Free Trades

Finder's Pick for
Commodity Stocks

Finder's Pick for
US Stocks

What's in this guide?
- Can I buy shares in Amdocs?
- Has coronavirus impacted Amdocs shares?
- Amdocs shares summary
- Compare share dealing platforms
- Is Amdocs stock a buy or sell?
- Amdocs performance over time
- Is Amdocs suitable for ethical investing?
- Are Amdocs shares over-valued?
- Amdocs's financials
- How volatile are Amdocs shares?
- Does Amdocs pay a dividend?
- Other common questions
Amdocs stock price (NASDAQ:DOX)
Use our graph to track the performance of DOX stocks over time.Amdocs shares at a glance
Latest market close | $83.33 |
---|---|
52-week range | $67.69 - $84.39 |
50-day moving average | $81.13 |
200-day moving average | $77.41 |
Wall St. target price | $90.50 |
PE ratio | 18.8191 |
Dividend yield | $1.44 (2.03%) |
Earnings per share (TTM) | $4.09 |
Compare stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Amdocs stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Amdocs price performance over time
Historical closes compared with the close of $83.33 from 2022-05-16
1 week (2022-05-06) | 5.37% |
---|---|
1 month (2022-04-13) | 0.70% |
3 months (2022-02-17) | 4.48% |
6 months (2021-11-17) | 13.44% |
1 year (2021-05-17) | 6.71% |
---|---|
2 years (2020-05-15) | 38.17% |
3 years (2019-05-17) | 37.06% |
5 years (2017-05-17) | 32.29% |
Is Amdocs under- or over-valued?
Valuing Amdocs stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amdocs's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Amdocs's P/E ratio
Amdocs's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, Amdocs shares trade at around 19x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Amdocs's PEG ratio
Amdocs's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.5242. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Amdocs's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Amdocs's EBITDA
Amdocs's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $826.6 million.
The EBITDA is a measure of a Amdocs's overall financial performance and is widely used to measure a its profitability.
Amdocs financials
Revenue TTM | $4.3 billion |
---|---|
Operating margin TTM | 14.36% |
Gross profit TTM | $1.5 billion |
Return on assets TTM | 5.76% |
Return on equity TTM | 14.03% |
Profit margin | 12.13% |
Book value | $28.65 |
Market capitalisation | $9.5 billion |
TTM: trailing 12 months
Amdocs's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Amdocs.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Amdocs's total ESG risk score
Total ESG risk: 20.97
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Amdocs's overall score of 20.97 (as at 12/31/2018) is pretty good – landing it in it in the 21st percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Amdocs is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Amdocs's environmental score
Environmental score: 6.71/100
Amdocs's environmental score of 6.71 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Amdocs is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Amdocs's social score
Social score: 15.33/100
Amdocs's social score of 15.33 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Amdocs is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Amdocs's governance score
Governance score: 10.44/100
Amdocs's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Amdocs is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Amdocs's controversy score
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Amdocs scored a 1 out of 5 for controversy – the highest score possible, reflecting that Amdocs has managed to keep its nose clean.
Amdocs share dividends
Dividend payout ratio: 39.76% of net profits
Recently Amdocs has paid out, on average, around 39.76% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.03% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Amdocs shareholders could enjoy a 2.03% return on their shares, in the form of dividend payments. In Amdocs's case, that would currently equate to about $1.44 per share.
While Amdocs's payout ratio might seem fairly standard, it's worth remembering that Amdocs may be investing much of the rest of its net profits in future growth.
Amdocs's most recent dividend payout was on 28 April 2022. The latest dividend was paid out to all shareholders who bought their shares by 29 March 2022 (the "ex-dividend date").
Amdocs share price volatility
Over the last 12 months, Amdocs's shares have ranged in value from as little as $67.685 up to $84.39. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amdocs's is 0.7456. This would suggest that Amdocs's shares are less volatile than average (for this exchange).
Amdocs overview
Amdocs Limited, through its subsidiaries, provides software and services worldwide. The company designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. It provides CES21, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; the Commerce and Care suite for order capture, handling, and customer engagement; the Monetization suite for charging, billing, policy, and revenue management; Intelligent Networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; MarketONE, a cloud-native business ecosystem; Digital Brands Suite, a pre-integrated digital business suite for digital telecom brands and small-scale service providers; and eSIM Cloud for service providers. It also offers AI-powered, cloud-native, and home operating systems; data intelligence solutions and applications; media services for media publishers, TV networks, and video streaming and service providers; end-to-end application development and maintenance services; and ongoing services. In addition, the company provides a line of services designed for various stages of a service provider's lifecycle includes design, delivery, quality engineering, operations, systems integration, mobile network services, consulting, and content services; managed services comprising application development, modernization and maintenance, IT and infrastructure services, testing and professional services that are designed to assist customers in the selection, implementation, operation, management, and maintenance of IT systems. It serves to the communications, cable and satellite, entertainment, and media industry service providers, as well as mobile virtual network operators and directory publishers. Amdocs Limited was founded in 1988 and is headquartered in Chesterfield, Missouri.
Stocks similar to Amdocs
Amdocs in the news
Is Amdocs Limited (NASDAQ:DOX) Trading At A 50% Discount?
Why Amdocs (DOX) is a Top Value Stock for the Long-Term

SEC filings reveal massive selling in media names, including Disney and Comcast
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing

Best brokerage signup bonuses in 2022
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.
Read more…
Popular propane stocks to buy in Canada
Here’s what you need to know about investing in the propane industry, including 3 popular propane stocks to watch.
Read more…
Best blue chip stocks in Canada and the US
Using our proprietary algorithm, we’ve found the best blue chip stocks on the TSX, NYSE and Nasdaq based on price, performance and more.
Read more…More guides on Finder
-
How to buy Hanover Bancorp, Inc. (HNVR) stock in Canada when it goes public
Everything we know about the Hanover Bancorp, Inc. IPO, plus information on how to buy in.
-
How to buy PrimeBlock stock in Canada when it goes public
Everything we know about the PrimeBlock IPO, plus information on how to buy in.
-
How to buy Actelis Networks (ASNS) stock in Canada when it goes public
Everything we know about the Actelis Networks IPO, plus information on how to buy in.
-
How to buy ProFrac Holding Corp (PFHC) stock in Canada when it goes public
Everything we know about the ProFrac Holding Corp IPO, plus information on how to buy in.
-
How to buy Wytec International (WYTC) stock in Canada when it goes public
Everything we know about the Wytec International IPO, plus information on how to buy in.
-
Inflation stocks
Here are some of the best stocks for inflation periods to reduce the negative impacts of inflation on your portfolio.
-
HSBC InvestDirect Review
Choose from many account and investment types to invest in global markets, but expect to pay high commissions with HSBC InvestDirect, which doesn’t have an app.
-
Flahmingo review
Our Flahmingo review tells you how to buy fractional shares of some of your favourite US companies with as little as $1.
-
How to buy Expeditors International of Washington stock in Canada
Steps to owning and managing EXPD stock, with 24-hour and historical pricing before you buy.
-
How to buy Perseus Mining stock in Canada
Steps to owning and managing PRU stock, with 24-hour and historical pricing before you buy.